// App-Quantinova.ai

TCT-403 : Bioresorbable Coronary Devices in Bifurcations: Immediate and 6-month Results of the REPARA Registry

Researchers

Presenter

  • Felipe Hernandez

Principal Investigators

  • Jose M. De la Torre Hernandez

  • Bruno Garcia

  • Jose Rumoroso

  • Ramiro Trillo

  • Armando Perez de Prado

  • eduardo molina

  • Raul Moreno

  • Jose Diaz

  • Ivan Gomez Blazquez

Medical Centers

  • Unknown, huelva, Spain

  • Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain

  • Hospital Do Meixoeiro, Vigo, Spain

  • Hospital Universitario del Mar, Barcelona, Spain

  • de Octubre, Madrid,Spain

  • Fundacion Investigacion Sanitaria en Leon, Leon, Spain

  • Gastroenterology, Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Portugal

  • Hospital de Santa Maria, Lisbon, Portugal

  • Hospital Galdakao-Usansolo, Usansolo, Spain

  • Unknown, granada, Spain

  • University Hospital La Paz, Madrid, Spain

  • Hospital Clinico Universitario, Santiago De Compostela, Spain

Locations

  • Spain

  • Portugal

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved